Insomnia Management, Dormotech offers DormoVision X as a solution for sleep clinics who provide care

Insomnia Management

Eliminate the "First-Night Effect" with Home-Based Sleep Studies

Contact

Multi-night analysis for accurate insomnia diagnosis and personalized treatment

Transform insomnia treatment with home-based, multi-night sleep studies that capture true sleep patterns and eliminate laboratory-induced sleep disturbances.

Key Benefits

Redefining Insomnia Management through Objective Phenotyping

High-Resolution Diagnostic Accuracy: Traditional single-night studies often fail to capture the physiological reality of chronic insomnia. DormoVision X™ allows for multi-night longitudinal assessment, revealing the true sleep patterns and underlying neurobiological drivers that a single, “stressful” lab night often masks.

Ecological Validity Natural Environment Data: By enabling patients to sleep in their own beds without the physical constraints of 20+ wires or nasal cannulas, the system eliminates the “First-Night Effect.” This captures an authentic representation of the patient’s typical sleep-onset latency and wake-after-sleep-onset (WASO) metrics, free from lab-induced hyperarousal.

Comprehensive Night-to-Night Variability Analysis: Insomnia is characterized by significant night-to-night fluctuation. Our platform provides the granular, 38-channel data needed to analyze these variances across multiple sessions, allowing clinicians to distinguish between transient disturbances and chronic physiological sleep-cycle disruptions.

Precision Treatment Optimization: Move beyond trial-and-error prescribing. With objective data on sleep staging and cortical arousals, clinicians can make data-driven therapy recommendations—whether adjusting CBT-I protocols, refining pharmacological interventions, or identifying comorbid sleep-disordered breathing that may be mimicking primary insomnia.

Features

  • One Platform, Full PSG Capability At Home or In-Lab.
  • Wireless, Remote, And FDA-Cleared.
  • 38 Total Channels For Comprehensive Sleep Data.
  • Faster Diagnoses with Greater Clinical Confidence.
  • Expand Capacity, Reduce Costs, No Added Overhead.
  • Patient-Friendly Solution for Diagnosing Complex Sleep Disorders in Children

 

Validated via NCT06224972 (N=47)

  • Nox A1 Comparison: Virtually identical mean AHI values recorded head-to-head.

  • Severity Match: Near-perfect alignment in distinguishing mild, moderate, and severe OSA cases.

  • Signal Reliability: Strong correlations across all secondary sleep parameters with minimal variance.

Keep up to date with our latest news and announcements!

Sign up with Dormotech to stay up to date on upcoming events, releases, and new research.